Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Clark

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|February 24, 2011
In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepaciaPamela McGhee, Catherine Clark, Kim Credito, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanismsPamela McGhee, Catherine Clark, Klaudia M Kosowska-Shick, et al.
Diagnostic Microbiology and Infectious Disease|May 12, 2004
In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactamsCatherine Clark, Klaudia Kosowska, Bülent Bozdogan, et al.
The Open Cardiovascular Medicine Journal|October 25, 2008
The ability of heart failure specialists to accurately predict NT-proBNP levels based on clinical assessment and a previous NT-proBNP measurementTara L Sedlak, Mann Chandavimol, Anna Calleja, et al.
Toxins|September 27, 2024
Utility of Cry1Ja for Transgenic Insect ControlJohn P Mathis, Catherine Clark, Amit Sethi, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Activity of LBM415 compared to those of 11 other agents against Haemophilus speciesTatiana Bogdanovich, Kathy A Smith, Catherine Clark, et al.
Journal of Medical Imaging and Radiation Oncology|August 24, 2017
Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trialRoya Merie, Lois Browne, Jaime S Cardoso, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2011
Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trialEric Hau, Lois H Browne, Sam Khanna, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agentsFrederick A Browne, Bülent Bozdogan, Catherine Clark, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporinKlaudia Kosowska, Dianne B Hoellman, Gengrong Lin, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|February 24, 2011
In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepaciaPamela McGhee, Catherine Clark, Kim Credito, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanismsPamela McGhee, Catherine Clark, Klaudia M Kosowska-Shick, et al.
Diagnostic Microbiology and Infectious Disease|May 12, 2004
In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactamsCatherine Clark, Klaudia Kosowska, Bülent Bozdogan, et al.
The Open Cardiovascular Medicine Journal|October 25, 2008
The ability of heart failure specialists to accurately predict NT-proBNP levels based on clinical assessment and a previous NT-proBNP measurementTara L Sedlak, Mann Chandavimol, Anna Calleja, et al.
Toxins|September 27, 2024
Utility of Cry1Ja for Transgenic Insect ControlJohn P Mathis, Catherine Clark, Amit Sethi, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Activity of LBM415 compared to those of 11 other agents against Haemophilus speciesTatiana Bogdanovich, Kathy A Smith, Catherine Clark, et al.
Journal of Medical Imaging and Radiation Oncology|August 24, 2017
Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trialRoya Merie, Lois Browne, Jaime S Cardoso, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2011
Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trialEric Hau, Lois H Browne, Sam Khanna, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agentsFrederick A Browne, Bülent Bozdogan, Catherine Clark, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporinKlaudia Kosowska, Dianne B Hoellman, Gengrong Lin, et al.
Pageof 5